Technology matrix
41wearables profiled
Map the devices
We profiled academic, startup and on-market wearables in a detailed technology matrix.
Case Study · Technology Landscape
Reading kidney injury through the skin.
A global medical device maker wanted to know if interstitial fluid could reveal acute kidney injury. We mapped wearable sensors and patents across every stage of commercialization and asked experts and clinicians where they fit.
The Client
The client is a global medical device manufacturer. It wanted to know which kidney injury biomarkers wearable sensors could measure.
The Challenge
Hidden signals.
Read them in the skin.
Prescouter was asked to map sensors, components and technologies at every stage, from academic to on-market, that could probe interstitial fluid or measure AKI biomarkers of interest.
-
Sensors
Wearable sensors
Devices that probe interstitial fluid.
-
Patents
Patent activity
Protected sensor ideas and components.
-
Clinic
Clinical practice
How AKI diagnosis could change.
Our Approach
Linking sensors to biomarkers with expert input.
Patent review
37patents reviewed
Check the patents
Patents on sensors and components showed which biomarkers could be measured in the future.
Expert interviews
9expert interviews
Ask the clinicians
Five business experts and four clinicians assessed sensor innovation and AKI clinical practice.
The Outcome
A roadmap for kidney sensing.
Prescouter profiled 41 wearable technologies and 37 patents over 4 rounds and conducted 9 interviews. The findings gave short, medium and long term direction for adding AKI interstitial fluid biomarkers to current and future sensors, especially wearables.
-
Devices
41 wearables
Across all stages of development.
-
Patents
37 patents
On sensors and components.
-
Voices
9 interviews
With business experts and clinicians.
A biomarker only matters if a sensor can read it and a clinician will act on it. Testing both sides early saves time.
Let’s Talk
Which biomarkers could your sensors read next?
Map the sensors, check the patents and hear from clinicians before you build. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]